Dr. Carrie B. Lee, MD

Dr. Lee practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Lee's NPI, 1538281928, was assigned on April 4, 2007. Dr. Lee graduated from Northeastern Ohio University College of Medicine in 2002.

Dr. Lee's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Lee's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Lee to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lee has a license on file in North Carolina.

CMS data shows 294 Medicare services from Dr. Lee across 4 procedure codes in 2024, for 58 Medicare patients. Medicare paid $14,802 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have cancer, and 74% have high blood pressure. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 73, with 63% women.

In 2024, Dr. Lee wrote 418 Medicare Part D claims for 66 patients. 60% of them were for generic drugs. CMS names the drug for 271 of them, across 11 drugs with 11 or more claims each, at $1,336,155 in total drug cost. In 2023, CMS named 133 claims across 6 drugs.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Lee, published from 2010 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Melanoma. Dr. Lee has published most often in J Thorac Oncol. Dr. Lee's most frequent co-authors are Mark A. Socinski, MD, Thomas E. Stinchcombe, MD and Frances A. Collichio, MD.

Dmand AI links Dr. Lee to 9 clinical trials, 3 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Carcinoma, Merkel Cell. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 18 general payments to Dr. Lee from 4 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 53% of the total. Genentech, Inc. paid the most, $6,604.

Dr. Lee graduated from Northeastern Ohio University College of Medicine in 2002.